- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 1084 results
Cases & Deals
February 5, 2026
King & Spalding advises KUFPEC on acquisition of 20% interest in Orca and Sul De Orca oil and gas blocks in Brazil
Press Release
February 4, 2026
Former DOJ Veteran Trial Lawyer, Acting U.S. Attorney, and White-Collar Section Chief Rejoins King & Spalding as Partner in Washington, D.C.
In the News · Source: Pink Sheet
February 3, 2026
Heather Bañuelos discusses the FDA increasingly citing promotional claims based on time-to-event endpoint data from single-arm trials
In the News · Source: Law.com
February 3, 2026
K&S is highlighted in a profile examining how the firm’s lobbying income rose in 2025
In the News · Source: Bloomberg Law
February 3, 2026
Doug Henderson examines the Rise St. James v. Louisiana Department of Environmental Quality case and explains its significance within the legal landscape
Press Release
February 3, 2026
King & Spalding Welcomes Nine-Partner Litigation Group in Expansion of Commercial and IP Litigation Capabilities
In the News · Source: The Federalist Society
February 3, 2026
William McClintock provides an analysis of the Barrett v. United States ruling and discusses its potential implications
In the News · Source: The American Lawyer, Law360 Pulse, Global Legal Chronicle, The Afternoon Docket, Attorney at Law Magazine and The National Law Journal
February 3, 2026
Rachel Gilbert, Cat Kirkland, Renee Rayne, Jim Gilliam and John Connell join the firm as partners in the Healthcare practice
Recognition
January 28, 2026
Legal 500 Germany Shortlists King & Spalding for Multiple Awards
Press Release
January 26, 2026
King & Spalding Welcomes Five-Partner Medicaid Financing and Managed Care Litigation Team